Select Page

Capital Evolution

At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.

Capital Evolution

Date of AllotmentNo. of equity shares issuedFace Value (Rs.)Type of IssueCumulative capital
(No. of equity shares)
01 March 1993200,00010.00Conversion of Partnership Firm200,000
30 March 1993700,00010.00Cash900,000
18 September 19935,100,00010.00Cash6,000,000
10 November 19931,000,00010.00Rights Issue7,000,000
08 January 1994185,00010.00Cash7,185,000
01 June 19943,592,50010.00Bonus Issue
(in the ratio 1:2)
10,777,500
09 August 1994323,40010.00Rights Issue11,100,900
08 December 19943,700,30010.00Public Issue14,801,200
07 February 1998413,63310.00Allotment pursuant to amalgamation of Tamilnadu Dadha Pharmaceuticals Ltd.
(in the ratio of 1:4)
15,214,833
25 March 1999208,00010.00Allotment pursuant to amalgamation of Milmet Laboratories Private Limited
(in the ratio of 4:5)
15,422,833
01 April 200030,844,46610.00Bonus Issue
(in the ratio 2:1)
46,267,299
06 June 2000477,58110.00Allotment pursuant to amalgamation of Gujarat Lyka Organics Limited
(In the ratio of 1:21.33)
46,744,880
16 January 200111,43810.00Allotment pursuant to amalgamation of Sun Pharmaceutical Exports Limited
(in the ratio of 4:5)
46,756,318
16 January 200120010.00Bonus (kept in abeyance)46,756,518
22 March 2001-50010.00Forfeited by the Board of Directors at their Board Meeting held on 22.03.200146,756,018
30 March 200218,51910.00Allotment pursuant to amalgamation of Pradeep Drug Company Limited
(in the ratio of 1:500)
46,774,537
28 August 200219,77110.00Allotment pursuant to amalgamation of M. J. Pharmaceuticals Limited
(in the ratio of 1:210)
46,794,308
21 January 200393,588,6165.00Sub-division/split of existing equity shares of Rs.10 each into two equity shares of Rs.5 each93,588,616
15 March 2003-209,0005.00Shares bought back destroyed93,379,616
28 March 2003-156,8385.00Shares bought back destroyed93,222,778
16 April 2003-174,3005.00Shares bought back destroyed93,048,478
08 May 2003-262,7325.00Shares bought back destroyed92,785,746
23 May 2003-30,0685.00Shares bought back destroyed92,755,678
08 June 200492,755,6785.00Bonus Issue
(in the ratio 1:1)
185,511,356
18 August 20054,2745.00Allotment pursuant to amalgamation of Phlox Pharmaceuticals Limited
(in the ratio of 1:790)
185,515,630
31 March 2006216,0075.00Allotment against conversion of FCCBs185,731,637
22 April 2006154,2915.00Allotment against conversion of FCCBs185,885,928
16 May 200661,7165.00Allotment against conversion of FCCBs185,947,644
07 June 200658,4455.00Allotment against conversion of FCCBs186,006,089
14 June 200661,7165.00Allotment against conversion of FCCBs186,067,805
04 September 200630,8585.00Allotment against conversion of FCCBs186,098,663
13 September 200698,7465.00Allotment against conversion of FCCBs186,197,409
16 September 2006462,8755.00Allotment against conversion of FCCBs186,660,284
09 October 2006306,6685.00Allotment against conversion of FCCBs186,966,952
11 October 200661,7165.00Allotment against conversion of FCCBs187,028,668
06 November 2006262,2935.00Allotment against conversion of FCCBs187,290,961
18 November 200650,9165.00Allotment against conversion of FCCBs187,341,877
20 November 2006462,8755.00Allotment against conversion of FCCBs187,804,752
05 December 2006828,5405.00Allotment against conversion of FCCBs188,633,292
06 December 2006185,1505.00Allotment against conversion of FCCBs188,818,442
18 December 20061,238,6485.00Allotment against conversion of FCCBs190,057,090
09 January 2007299,3245.00Allotment against conversion of FCCBs190,356,414
18 January 2007706,6545.00Allotment against conversion of FCCBs191,063,068
19 January 2007216,0085.00Allotment against conversion of FCCBs191,279,076
03 February 2007623,3335.00Allotment against conversion of FCCBs191,902,409
22 February 2007222,1795.00Allotment against conversion of FCCBs192,124,588
23 February 2007135,4675.00Allotment against conversion of FCCBs192,260,055
09 March 2007277,7255.00Allotment against conversion of FCCBs192,537,780
31 March 2007864,3405.00Allotment against conversion of FCCBs193,402,120
21 April 20071,016,7785.00Allotment against conversion of FCCBs194,418,898
19 May 2007518,4175.00Allotment against conversion of FCCBs194,937,315
09 June 20071,139,9015.00Allotment against conversion of FCCBs196,077,216
28 June 20071,018,3235.00Allotment against conversion of FCCBs197,095,539
21 July 2007842,4305.00Allotment against conversion of FCCBs197,937,969
11 August 20071,247,9725.00Allotment against conversion of FCCBs199,185,941
14 October 2007339,4415.00Allotment against conversion of FCCBs199,525,382
20 October 2007864,0345.00Allotment against conversion of FCCBs200,389,416
03 November 2007509,1615.00Allotment against conversion of FCCBs200,898,577
01 December 2007208,5995.00Allotment against conversion of FCCBs201,107,176
29 December 2007339,4395.00Allotment against conversion of FCCBs201,446,615
25 January 200830,8585.00Allotment against conversion of FCCBs201,477,473
01 March 20083,120,0845.00Allotment against conversion of FCCBs204,597,557
20 March 20082,518,8345.00Allotment against conversion of FCCBs207,116,391
29 November 20101,035,581,9551.00Sub-division/split of existing equity shares of Rs.5 each into five equity shares of Re.1 each1,035,581,955
03 August 20131,035,581,9551.00Bonus Issue
(in the ratio 1:1)
2,071,163,910
10 April 2015334,956,7641.00Allotment pursuant to amalgamation of Ranbaxy Laboratories Limited
(in the ratio of 8:10)
2,406,120,674
29 April 201521,8641.00Shares allotted under ESOS2,406,142,538
29 April 201563,3961.00Shares allotted under ESOS2,406,205,934
29 April 201544,5091.00Shares allotted under ESOS2,406,250,443
29 April 201517,1361.00Shares allotted under ESOS2,406,267,579
29 April 2015143,7691.00Shares allotted under ESOS2,406,411,348
29 April 201512,0001.00Shares allotted under ESOS2,406,423,348
23 July 201512,4921.00Shares allotted under ESOS2,406,435,840
23 July 201518,1281.00Shares allotted under ESOS2,406,453,968
23 July 201511,4041.00Shares allotted under ESOS2,406,465,372
23 July 20158,2441.00Shares allotted under ESOS2,406,473,616
23 July 201522,5211.00Shares allotted under ESOS2,406,496,137
31 October 20158,4321.00Shares allotted under ESOS2,406,504,569
31 October 20157,1141.00Shares allotted under ESOS2,406,511,683
31 October 20156,3001.00Shares allotted under ESOS2,406,517,983
31 October 20155,3281.00Shares allotted under ESOS2,406,523,311
31 October 201512,7391.00Shares allotted under ESOS2,406,536,050
31 October 2015130,0001.00Shares allotted under ESOP2,406,666,050
12 February 201616,9731.00Shares allotted under ESOS2,406,683,023
12 February 20163,5761.00Shares allotted under ESOS2,406,686,599
12 February 20163,9121.00Shares allotted under ESOS2,406,690,511
12 February 20162,3041.00Shares allotted under ESOS2,406,692,815
12 February 20165,6841.00Shares allotted under ESOS2,406,698,499
12 February 201630,0001.00Shares allotted under ESOP2,406,728,499
02 May 20163,9501.00Shares allotted under ESOS2,406,732,449
02 May 20162,9581.00Shares allotted under ESOS2,406,735,407
02 May 20163,7081.00Shares allotted under ESOS2,406,739,115
02 May 201614,8441.00Shares allotted under ESOS2,406,753,959
21 October 2016-7,500,0001.00Shares bought back destroyed2,399,253,959
22 November 20164,7801.00Shares allotted under ESOS2,399,258,739
22 November 20163,4041.00Shares allotted under ESOS2,399,262,143
22 November 20162,3401.00Shares allotted under ESOS2,399,264,483
22 November 20165,7051.00Shares allotted under ESOS2,399,270,188
14 February 201711,3341.00Shares allotted under ESOS2,399,281,522
14 February 20173,0261.00Shares allotted under ESOS2,399,284,548
14 February 20173,2331.00Shares allotted under ESOS2,399,287,781
14 February 20173,4001.00Shares allotted under ESOS2,399,291,181
26 May 20171,5601.00Shares allotted under ESOS2,399,292,741
26 May 20173601.00Shares allotted under ESOS2,399,293,101
26 May 20171,0801.00Shares allotted under ESOS2,399,294,181
26 May 201712,0001.00Shares allotted under ESOP2,399,306,181
11 August 20172441.00Shares allotted under ESOS2,399,306,425
11 August 20171801.00Shares allotted under ESOS2,399,306,605
11 August 20173751.00Shares allotted under ESOS2,399,306,980
26 September 20171,1061.00Shares allotted under ESOP2,399,308,086
14 November 20171,2601.00Shares allotted under ESOS2,399,309,346
14 February 201812,6521.00Shares allotted under ESOS2,399,321,998
14 February 20187921.00Shares allotted under ESOS2,399,322,790
14 February 20183901.00Shares allotted under ESOS2,399,323,180
24 May 20187201.00Shares allotted under ESOS2,399,323,900
24 May 20185941.00Shares allotted under ESOS2,399,324,494
13 August 20181801.00Shares allotted under ESOS2,399,324,674
12 November 20182,1601.00Shares allotted under ESOS2,399,326,834
12 November 20181,4401.00Shares allotted under ESOS2,399,328,274
11 February 20196,6961.00Shares allotted under ESOS2,399,334,970

Note :
Shares allotted under ESOS – Allotment under Sun Employee Stock Option Scheme -2015 to employees
Shares allotted under ESOP – Allotment under Sun Employee Stock Option Plan -2015 to Sun Pharma ESOP Trust for allocation to employees

Top